GDRX Q1 2022 Earnings — GoodRx Holdings, Inc. Revenue & Financial Results | Market Cap Arena

GDRXGoodRx Holdings, Inc.

$829M

Q1 2022 Earnings

Healthcare Medical - Healthcare Information Services

Income Statement

Revenue

$203M+26.7% YoY

Gross Profit

$191M94.0% margin

Operating Income

$20M9.7% margin

Net Income

$12M6.0% margin

EPS (Diluted)

$0.03

QoQ Revenue Growth

-4.7%

Cash Flow

Operating Cash Flow

$30M

Free Cash Flow

$18M

Stock-Based Comp.

$30M

Balance Sheet

Total Assets

$1.5B

Total Liabilities

$752M

Stockholders' Equity

$787M

Cash & Equivalents

$845M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$203M	$160M	+26.7%
Gross Profit	$191M	$150M	+27.4%
Operating Income	$20M	-$5M	+495.4%
Net Income	$12M	$2M	+637.0%

Revenue Segments

Prescription Transactions Revenue

$156M76%

Pharma Manufacturer Solutions Revenues

$23M12%

Subscription Revenue

$19M9%

Other Revenue

$5M3%